Aspen agrees to buy GSK drugs for $967 million

South Africa's Aspen Pharmacare said on Monday it had agreed to a price of 600 million pounds to buy thrombosis drugs and a factory from shareholder GlaxoSmithKline . Aspen and Britain's Glaxo first announced ...

by via Yahoo! Finance: Top Stories